SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity, in the life sciences segment of the health care sector, today launched the Twist Oncology DNA Comprehensive Genomic Profiling (CGP) Panel, a customizable, research-use-only solution designed to empower users to identify genomic alterations for a broad set of tumors, guide […]

SINGAPORE — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately. Nilesh brings over 25 years of leadership experience in the medical technology and life sciences industries, having held senior roles at Johnson & Johnson, GE Healthcare and most […]

Believes Years of Self-Inflicted Issues Have Caused Avantor to Trade at a Meaningful Discount to its Intrinsic Value and Life Sciences Peers Contends the Board Has Failed to Remedy Operating Underperformance, Ineffective Cost Controls and Poor Capital Deployment – Resulting in Significant Value Destruction Over Every Relevant Period Makes Clear the Board Needs to Be […]

Emmanuel Ligner, Seasoned Leader with Proven Track Record of Value Creation in Life Sciences, to Begin Role as CEO Next Week RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today issued the following statement in response to the […]

Acquisition Will Further Expand Chromium’s Capabilities PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has signed a definitive agreement to acquire Scale Biosciences, Inc., a leader in innovative and scalable single cell analysis. The acquisition provides 10x with key inventions and technologies that will advance innovation […]

ANN ARBOR, Mich. — Excellos, Lonza, and Akadeum Life Sciences today announce a new project aimed at redefining standards for cell therapy manufacturing by elevating the role of starting material quality. This project brings together leaders in donor cell characterization, automated manufacturing, and cell separation technology to explore how aligned, modular innovation can streamline workflows and […]

Consent Judgment confirms Aobious infringed Promega patents covering luciferase substrate compounds Settlement includes permanent injunction against Aobious and monetary payments to Promega Promega reaffirms commitment to providing high-quality reagents to scientists through authorized distribution channels MADISON, Wis.–Promega Corporation and Aobious Inc. have entered into a settlement agreement to resolve a patent infringement lawsuit related to […]

WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team. Jonathan […]

Shimadzu Corporation and Kyoto University (Yoshida-honmachi, Sakyo-ku, Kyoto-shi) have signed a comprehensive collaborative agreement with the objective of creating new business activities and innovation to contribute to solving social problems, and training global high-level human resources. In 2022, both parties signed a three-year comprehensive collaborative agreement with the objective of creating new business activities by […]

Illumina TruSight™ Oncology 500 v2 research assay is now available with built-in HRD biomarker detection, faster turnaround time, and lower tissue sample input Illumina’s growing research and clinical oncology portfolio broadens access to critical biomarker testing SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its […]